InflaRx NV Share Price Today: Live Updates & Key Insights
InflaRx NV share price today is $0.9588, up 3.34%. The stock opened at $0.9576 against the previous close of $0.9096, with an intraday high of $0.9999 and low of $0.9217.
InflaRx NV Share Price Chart
InflaRx NV Share Price Performance
InflaRx NV Institutional Holdings
InflaRx NV Market Status
InflaRx NV Fundamentals
Market Cap 63.68 M
PB Ratio 1.2245
PE Ratio 0.0
Enterprise Value 13.12 M
Total Assets 55.19 M
Volume 1030350
InflaRx NV Company Financials
About InflaRx NV & investment objective
Company Information InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
Organisation Biotechnology
Employees 74
Industry Biotechnology
CEO Prof. Niels C. Riedemann M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
InflaRx NV FAQs
What is the share price of InflaRx NV today?
The current share price of InflaRx NV is $0.9588.
Can I buy InflaRx NV shares in India?
Yes, Indian investors can buy InflaRx NV shares by opening an international trading and demat account with Motilal Oswal.
How to buy InflaRx NV shares in India?
You can easily invest in InflaRx NV shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy InflaRx NV shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of InflaRx NV.
Can I buy fractional shares of InflaRx NV?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of InflaRx NV?
InflaRx NV has a market cap of $63.68 M.
In which sector does InflaRx NV belong?
InflaRx NV operates in the Biotechnology sector.
What documents are required to invest in InflaRx NV stocks?
To invest, you typically need:
What is the PE and PB ratio of InflaRx NV?
The PE ratio of InflaRx NV is N/A and the PB ratio is 1.22.